France – Produits pharmaceutiques – DEC : Essai clinique EFFICAZI
AI summary
This tender concerns the supply of experimental pharmaceutical products for the EFFICAZI double-blind clinical trial promoted by Assistance Publique - Hôpitaux de Paris (AP-HP). The study aims to evaluate the efficacy and safety of investigational medicines in a controlled clinical setting.
Pharmaceutical companies with experience in manufacturing investigational drugs, clinical trial supply chain management, and regulatory compliance in France should apply.
Suppliers must be qualified pharmaceutical manufacturers or distributors capable of producing and delivering investigational medicinal products compliant with GMP standards and clinical trial regulations. Documentation of regulatory approval and quality assurance procedures is required.
Frequently asked questions
What is this tender about?
This tender concerns the supply of experimental pharmaceutical products for the EFFICAZI double-blind clinical trial promoted by Assistance Publique - Hôpitaux de Paris (AP-HP). The study aims to evaluate the efficacy and safety of investigational medicines in a controlled clinical setting.
What are the requirements for suppliers?
Suppliers must be qualified pharmaceutical manufacturers or distributors capable of producing and delivering investigational medicinal products compliant with GMP standards and clinical trial regulations. Documentation of regulatory approval and quality assurance procedures is required.
What type of company should bid?
Pharmaceutical companies with experience in manufacturing investigational drugs, clinical trial supply chain management, and regulatory compliance in France should apply.
Who is the buyer?
The buyer is AGEPS de l'AP-HP.
When does this tender close?
Submissions close on May 12, 2026.
Fourniture de médicaments expérimentaux pour l’essai clinique EFFICAZI en double insu promu par l'Assistance Publique - Hôpitaux de Paris (AP-HP) promoteur de l'étude.
DEC : Essai clinique EFFICAZI
Fourniture de médicaments expérimentaux pour l’essai clinique EFFICAZI en double insu promu par l'Assistance Publique - Hôpitaux de Paris (AP-HP) promoteur de l'étude.
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…